Cargando…
Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases
Neuroendocrine tumor (NET) patients must be adequately staged in order to improve a multidisciplinary approach and optimal management for metastatic disease. Currently available imaging studies include somatostatin receptor scintigraphy, like OctreoScan®, computed tomography (CT), scans and magnetic...
Autores principales: | Cossetti, Rachel Jorge D, Bezerra, Regis Otaviano França, Gumz, Brenda, Telles, Adriana, Costa, Frederico P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472201/ https://www.ncbi.nlm.nih.gov/pubmed/22591909 http://dx.doi.org/10.1186/1477-7819-10-82 |
Ejemplares similares
-
Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
por: Corrias, Giuseppe, et al.
Publicado: (2017) -
Does Octreoscan add value in the differential diagnosis of
parapharyngeal space lesions?
por: Dias, Raquel Baptista, et al.
Publicado: (2021) -
111In-Octreoscan SPECT/CT hybrid imaging and 68Ga-DOTANOC PET/CT in neuroendocrine adenoma of the middle ear (NAME)
por: Pontico, Mariano, et al.
Publicado: (2020) -
Spontaneous combined rupture of a pelvicalyceal cyst into the collector system and retroperitoneal space during the acquisition of computed tomography scan images: a case report
por: Marques, Diogo Torres, et al.
Publicado: (2012) -
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report
por: Gagliato, Debora de Melo, et al.
Publicado: (2016)